| |
Pre-Clinical |
Clinical |
|
| |
Lead Optimization |
IND Enabling |
IND Filing |
Phase 1 |
Phase 2 |
Phase 3 |
Market |
PV-10
Melanoma |
- Orphan drug status Jan 2007
- Phase 2 initiated Sep 2007
- Phase 2 recruitment completed May 2009
|
PH-10
Psoriasis |
- Phase 2 initiated Nov 2007
- Replacement Phase 2 initiated Jul 2009 due to dose regimen change
- Phase 2 recruitment completed Oct 2009
- Phase 2 study completed Apr 2010
|
PH-10
Atopic Dermatitis |
- Phase 2 initiated Jun 2008
- Phase 2 recruitment completed Jun 2009
- Phase 2 study completed Sep 2009
|
PV-10
Breast Cancer |
- Phase 1 completed Jul 2008
|
PV-10
Liver Metastasis |
- Phase 1 initiated Oct 2009
|
